24 May 2013
Keywords: roche, restrict, ads, acne, drug, hoffmann-la, working
Article | 02 November 2000
Hoffmann-La Roche is working with the US Food and Drug Administrationto limit direct-to-consumer advertising for its acne drug
Roaccutane/Accutane ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 November 2000
1 November 2000
23 May 2013
© 2013 thepharmaletter.com